Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2
- PMID: 16424383
- PMCID: PMC2644221
- DOI: 10.1165/rcmb.2005-0300OC
Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2
Abstract
The TSC1 and TSC2 proteins, which function as a TSC1/TSC2 tumor suppressor complex, are associated with lymphangioleiomyomatosis (LAM), a genetic disorder characterized by the abnormal growth of smooth muscle-like cells in the lungs. The precise molecular mechanisms that modulate LAM cell growth remain unknown. We demonstrate that TSC2 regulates LAM cell growth. Cells dissociated from LAM nodules from the lungs of five different patients with LAM have constitutively activated S6K1, hyperphosphorylated ribosomal protein S6, activated Erk, and increased DNA synthesis compared with normal cells from the same patients. These effects were augmented by PDGF stimulation. Akt activity was unchanged in LAM cells. Rapamycin, a specific S6K1 inhibitor, abolished increased LAM cell growth. The full-length TSC2 was necessary for inhibition of S6 hyperphosphorylation and DNA synthesis in LAM cells, as demonstrated by co-microinjection of the C-terminus, which contains the GTPase activating protein homology domain, and the N-terminus, which binds TSC1. Our data demonstrate that increased LAM cell growth is associated with constitutive S6K1 activation, which is extinguishable by TSC2 expression. Loss of TSC2 GAP activity or disruption of the TSC1/TSC2 complex dysregulates S6K1 activation, which leads to abnormal cell proliferation associated with LAM disease.
Figures
![<b>Figure 1.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig1.gif)
![<b>Figure 2.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig2a.gif)
![<b>Figure 2.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig2a.gif)
![<b>Figure 3.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig3a.gif)
![<b>Figure 3.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig3a.gif)
![<b>Figure 4.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig4.gif)
![<b>Figure 5.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig5.gif)
![<b>Figure 6.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig6.gif)
![<b>Figure 7.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig7a.gif)
![<b>Figure 7.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig7a.gif)
![<b>Figure 7.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig7a.gif)
![<b>Figure 7.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2644221/bin/AJRCMB345561fig7a.gif)
Similar articles
-
Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.Mol Pharmacol. 2008 Mar;73(3):778-88. doi: 10.1124/mol.107.040824. Epub 2007 Dec 19. Mol Pharmacol. 2008. PMID: 18094073
-
Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).J Biol Chem. 2002 Aug 23;277(34):30958-67. doi: 10.1074/jbc.M202678200. Epub 2002 Jun 3. J Biol Chem. 2002. PMID: 12045200
-
Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.Mod Pathol. 2006 Jun;19(6):839-46. doi: 10.1038/modpathol.3800610. Mod Pathol. 2006. PMID: 16575396
-
Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.Proc Am Thorac Soc. 2008 Jan 1;5(1):119-26. doi: 10.1513/pats.200705-061VS. Proc Am Thorac Soc. 2008. PMID: 18094094 Free PMC article. Review.
-
LAM cells biology and lymphangioleiomyomatosis.Folia Histochem Cytobiol. 2013;51(1):1-10. doi: 10.5603/FHC.2013.001. Folia Histochem Cytobiol. 2013. PMID: 23690211 Review.
Cited by
-
Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy.Intern Med. 2024 Jul 15;63(14):2043-2047. doi: 10.2169/internalmedicine.2847-23. Epub 2023 Nov 27. Intern Med. 2024. PMID: 38008448 Free PMC article.
-
Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis.Front Immunol. 2022 Mar 1;13:844914. doi: 10.3389/fimmu.2022.844914. eCollection 2022. Front Immunol. 2022. PMID: 35300340 Free PMC article.
-
A Mixed Blood-Lymphatic Endothelial Cell Phenotype in Lymphangioleiomyomatosis and Idiopathic Pulmonary Fibrosis but Not in Kaposi's Sarcoma or Tuberous Sclerosis Complex.Am J Respir Cell Mol Biol. 2022 Mar;66(3):337-340. doi: 10.1165/rcmb.2021-0293LE. Am J Respir Cell Mol Biol. 2022. PMID: 35102814 Free PMC article. No abstract available.
-
Raising the Flag for Mast Cells as a Novel Target in Lymphangioleiomyomatosis.Am J Respir Crit Care Med. 2021 Aug 15;204(4):387-389. doi: 10.1164/rccm.202104-0872ED. Am J Respir Crit Care Med. 2021. PMID: 33951405 Free PMC article. No abstract available.
-
Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.Sci Rep. 2018 Oct 2;8(1):14698. doi: 10.1038/s41598-018-32795-3. Sci Rep. 2018. PMID: 30279475 Free PMC article.
References
-
- Moss J. LAM and other diseases characterized by smooth muscle proliferation. New York, Basel: Marcel Dekker; 1999.
-
- Johnson SR, Tattersfield AE. Lymphangioleiomyomatosis. Semin Respir Crit Care Med 2002;23:85–92. - PubMed
-
- Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998;114:1689–1703. - PubMed
-
- Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med 2001;163:253–258. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous